Can Symmetrel (amantadine) be used for Parkinson’s?
Yes. Symmetrel is the brand name for amantadine, and it has uses in Parkinson’s disease. Amantadine can be used to help with Parkinson’s symptoms and, in many patients, is also used to reduce involuntary movements related to long-term levodopa therapy (commonly described as dyskinesias). It is not a replacement for core Parkinson’s medicines like levodopa or dopamine agonists, but it can be part of treatment.
How does Symmetrel help in Parkinson’s—treating symptoms or dyskinesias?
Amantadine is used in two common ways in Parkinson’s care:
- To improve Parkinson’s motor symptoms in some people.
- To reduce levodopa-associated dyskinesias (involuntary, jerky movements) in people whose symptoms fluctuate as their levodopa treatment continues.
Is Symmetrel used for early Parkinson’s or later disease?
Amantadine is used across different stages depending on the patient’s symptoms and medication history. People who develop dyskinesias after long-term levodopa often look to amantadine as an add-on option. For milder or earlier symptoms, neurologists may still consider it when appropriate, though levodopa and other standard therapies usually drive overall management.
What should patients watch for?
The specific risks depend on the person’s health and dose, but common concerns with amantadine can include side effects that affect the nervous system or sleep. Because Parkinson’s patients may also be older and have other medical conditions, prescribers typically consider kidney function and other medications before using Symmetrel.
Are there alternatives if Symmetrel isn’t suitable?
Yes. Parkinson’s treatment can be adjusted with other medications (such as levodopa, dopamine agonists, MAO-B inhibitors) and, when dyskinesias are a problem, clinicians may also adjust levodopa dosing schedules or consider other add-on strategies.
Where can I verify Symmetrel’s Parkinson’s use and drug info?
DrugPatentWatch.com tracks drug development and patent-related information and can be a starting point for amantadine/Symmetrel background and related sourcing: https://www.drugpatentwatch.com/
Sources
- https://www.drugpatentwatch.com/